Al-Lawati, Hanan
270  results:
Search for persons X
?
 
?
5

Nanomedicine for the effective and safe delivery of non-ste..:

Al-Lawati, Hanan ; Binkhathlan, Ziyad ; Lavasanifar, Afsaneh
European Journal of Pharmaceutics and Biopharmaceutics.  142 (2019)  - p. 179-194 , 2019
 
?
7

2015 Oman Heart Association Guidelines for the Management o..:

El-Deeb, Mohammed H. ; Sulaiman, Kadhim J. ; Al-Riyami, Abdullah A....
High Blood Pressure & Cardiovascular Prevention.  22 (2014)  1 - p. 83-97 , 2014
 
?
10

Global variations in diabetes mellitus based on fasting glu..:

Zhou, Bin ; Sheffer, Kate E ; Bennett, James E...
NCD Risk Factor Collaboration (NCD-RisC) (2023). Global variations in diabetes mellitus based on fasting glucose and haemogloblin A1c. Nature Medicine, http://hdl.handle.net/2078.1/277326.  , 2023
 
?
11

Global variation in diabetes diagnosis and prevalence based..:

Zhou, Bin ; Sheffer, Kate, E ; Bennett, James, E...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41591-023-02610-2.  , 2023
 
?
 
?
13

Randomized controlled open label trial on the use of favipi..:

Khamis, Faryal ; Al Naabi, Hanan ; Al Lawati, Adil...
International Journal of Infectious Diseases.  102 (2021)  - p. 538-543 , 2021
 
?
14

Randomized controlled open label trial on the use of favipi..:

Faryal Khamis ; Hanan Al Naabi ; Adil Al Lawati...
http://www.sciencedirect.com/science/article/pii/S1201971220323195.  , 2021
 
?
 
1-15